Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Clinical trial NCT03945162 · RECRUITING

Trial details

NCT number: NCT03945162
Sponsor: Theralase® Technologies Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Start date: 2019-08-30
Primary completion: 2026-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.